City
Epaper

Byju’s, Pharmeasy 'large underperformers' in Prosus’ India H1 FY24 portfolio

By IANS | Updated: November 29, 2023 19:20 IST

New Delhi, Nov 29 Investment firm Prosus has identified edtech firmAccording to the company's half-yearly financials report, ...

Open in App

New Delhi, Nov 29 Investment firm Prosus has identified edtech firm

According to the company's half-yearly financials report, while Byju's had a negative internal rate of return (IRR) of 24 per cent, Pharmaeasy had a negative IRR of 41 per cent in H1 FY24, reports Moneycontol.

Prosus has also marked down the value of its stake in Byju’s to less than $3 billion, representing a decline of more than 86 per cent from the previous funding round valuation of $22 billion.

Since 2018, Prosus has invested $536 million in Byju's. It revalued the investment to $493 million in June, an 8 per cent decrease. In addition to Prosus, Byju's early sponsor Blackrock has reduced its interest in the company.

In November last year, Prosus first slashed the fair value of Byju's to $5.97 billion.

"Byju's is more challenged and the company is facing multiple headwinds. We and other shareholders are working everyday to improve the situation. We are in close discussions with the company every day," a senior Prosus executive said.

While debt investors sued the edtech firm after it missed payment deadlines, Peak XV (formerly Sequoia), Prosus, and Chan Zuckerberg resigned from Byju's board after the company failed to submit its audited financial records for FY22 and FY23.

Prosus has also slashed Pharmeasy's valuation down to half from $5.6 billion, while the company is attempting to raise a new round at a lower valuation of up to 90 per cent, the report mentioned.

"Another is a write down in Pharmeasy of about $118 million and that's really driven by the need for Pharmeasy to raise money to settle debt. We actually participated in that round which expresses our confidence in the business going forward," a Prosus spokesperson was quoted as saying.

Meanwhile, Prosus gained profits from other Indian companies in its portfolio, such as Swiggy, Eruditus, PayU India, Meesho, and Elastic Run.

Swiggy generated a 7 per cent IRR for Prosus, while Eruditus generated a 22 per cent IRR. In the first of FY24, it also achieved 30 per cent positive returns from PayU India, 32 per cent from Meesho, and 31 per cent from Elastic Run.

Disclaimer: This post has been auto-published from an agency feed without any modifications to the text and has not been reviewed by an editor

Open in App

Related Stories

InternationalBangladesh Students’ League urges neutral administration for inclusive 2026 elections

International11 Afghan nationals dead in Nokundi road accident

TechnologyS. Korea develops tech for world's 2nd-fastest 370 kph high-speed train

Other SportsBundesliga: Bayern cruise through Heidenheim to close year in control

BusinessS. Korea develops tech for world's 2nd-fastest 370 kph high-speed train

International Realted Stories

InternationalSouth Korea dismisses report on proposing legal revision to recognise North Korea as separate nation

InternationalAustralia mulls gas reservation for domestic use

InternationalSouth Korea: Parliamentary probe into Jeju Air crash begins

International"Strain entirely of Yunus' making," Sheikh Hasina blames interim government for stressed relations with India

InternationalAfrican leaders call for regional-led solution to Congo conflict